Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Escitalopram Hbr Taj Pharmaceuticals

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Escitalopram Hbr Manufacturers in India Suppliers Escitalopram Hbr Exporters Distributors Escitalopram Hbr api active pharmaceuticals ingredients Escitalopram Hbr manufacturers Side Effects bulk drugs raw material Escitalopram Hbr companies Side Effects Importers Escitalopram Hbr Escitalopram Hbr Exporters Escitalopram Hbr exporters FDA Escitalopram Hbr DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Escitalopram Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Escitalopram Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Escitalopram Hydrochloride active pharmaceutical ingredients Escitalopram Hydrochloride committee active pharmaceutical ingredients manufacturer Escitalopram Hydrochloride Active Pharmaceutical Ingredients manufacturer Escitalopram Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Escitalopram Hbr, Escitalopram Hbr manufacturer India, Escitalopram Hbr product, Escitalopram Hbr products, Api preparation, Certificate of Analysis API manufacturer product, Escitalopram Hbr anti ulcer product, Certificate of Origin COA Escitalopram Hbr COS Escitalopram Hbr, pharmaceutical generic, pharmaceutical drug, medical, Escitalopram Hbr pharma healthcare, pharma patents, contract MSDS manufacturing Trader Escitalopram Hbr pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Escitalopram Hbr expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Escitalopram Hbr DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Escitalopram Hbr ingredients, api, HIV Escitalopram Hbr, tablets, capsules, syrup & protein Escitalopram Hbr powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Escitalopram Hbr gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Escitalopram Hbr WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Escitalopram HBr  left-banner













 








 

 

HOME >> API >> API List1 >> Escitalopram Hbr >> Precautions

Molecular Weight 324.39

PRECAUTIONS
Escitalopram CAS NO 128196-01-0

Tell your doctor your medical history, especially of: liver problems, kidney problems, seizures, heart problems, other mental/mood disorders (e.g., bipolar disorder), thyroid problems, mineral (electrolyte) problems (e.g., hyponatremia, SIADH), any allergies. This drug may make you dizzy or drowsy; use caution engaging in activities requiring alertness such as driving or using machinery. Limit alcoholic beverages. Though uncommon, depression can lead to thoughts or attempts of suicide. Tell your doctor immediately if you have any suicidal thoughts, worsening depression, or any other mental/mood changes (including new or worsening anxiety, agitation, panic attacks, trouble sleeping, irritability, hostile/angry feelings, impulsive actions, severe restlessness, rapid speech). Keep all medical appointments so your healthcare professional can monitor your progress closely and adjust/change your medication if needed. Caution is advised when using this drug in the elderly because they may be more sensitive to the effects of the drug. This medication should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your doctor. If this medication is used during the last 3 months of pregnancy, infrequently your newborn may develop symptoms including feeding or breathing difficulties, seizures, muscle stiffness, jitteriness, or constant crying. However, do not stop taking this medication unless your doctor directs you to do so. Report any such symptoms to your doctor promptly. This drug passes into breast milk. Because of the potential risk to the infant, breast-feeding while using this drug is not recommended. Consult your doctor before breast-feeding.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS >>
INTERACTION
PHARMALOGY
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Escitalopram HBr

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 



taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.